UBS(Lux)E.F.-Biotech(USD)QL a.USD/ LU2208649280 /
NAV2024-07-24 | Chg.-0.3800 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
110.6300USD | -0.34% | reinvestment | Equity Worldwide | UBS Fund M. (LU) ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020 | - | - | - | - | - | - | - | - | - | -4.85 | 10.82 | 5.59 | - |
2021 | -0.74 | -3.22 | -2.89 | 2.29 | -1.37 | 9.21 | -1.46 | 5.26 | -6.23 | -2.93 | -4.13 | 2.71 | -4.47% |
2022 | -11.56 | -2.62 | 4.22 | -9.81 | -3.80 | 5.96 | 1.53 | 5.31 | -0.88 | 5.53 | 7.04 | -6.04 | -7.18% |
2023 | 1.43 | -5.94 | 0.90 | 0.74 | -2.65 | 1.14 | 2.77 | -1.89 | -4.06 | -8.80 | 5.13 | 15.93 | +2.68% |
2024 | -2.76 | -0.56 | 1.87 | -8.33 | 9.30 | 3.87 | 4.97 | - | - | - | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 19.07% | 19.24% | 19.86% | 22.18% | -% |
Sharpe ratio | 0.54 | 0.80 | 0.45 | -0.21 | - |
Best month | +15.93% | +9.30% | +15.93% | +15.93% | - |
Worst month | -8.33% | -8.33% | -8.80% | -11.56% | - |
Maximum loss | -15.10% | -11.49% | -15.75% | -35.76% | - |
Outperformance | - | - | - | - | - |
All quotes in USD
Share classes
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
UBS(Lux)E.F.-Biotech(USD)P a.SEK | reinvestment | 1,053.6600 | +15.18% | +17.15% | |
UBS(Lux)E.F.-Biotech(USD)QL a.US... | reinvestment | 110.6300 | +12.65% | -2.61% | |
UBS(Lux)E.F.-Biotech(USD)Q a.USD | reinvestment | 340.1500 | +12.42% | -3.19% | |
UBS (Lux) Equity Fund - Biotech ... | reinvestment | 108.1100 | +14.75% | - | |
UBS (Lux) Equity Fund - Biotech ... | reinvestment | 766.3100 | +11.28% | -6.11% |
Performance
YTD | +7.61% | ||
---|---|---|---|
6 Months | +9.13% | ||
1 Year | +12.65% | ||
3 Years | -2.61% | ||
5 Years | - | ||
10 Years | - | ||
Since start | +10.31% | ||
Year | |||
2023 | +2.68% | ||
2022 | -7.18% | ||
2021 | -4.47% |